Technical Analysis for HTBX - Heat Biologics, Inc.

Grade Last Price % Change Price Change
grade F 0.43 -0.39% 0.00
HTBX closed down 0.39 percent on Monday, November 18, 2019, on 73 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical HTBX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.39%
Narrow Range Bar Range Contraction -0.39%
NR7 Range Contraction -0.39%
Inside Day Range Contraction -0.39%
Wide Bands Range Expansion -0.39%
Oversold Stochastic Weakness -0.39%
20 DMA Resistance Bearish -1.15%

Older signals for HTBX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
HTBX Chart by TradingView
Basic chart:
Profile
Heat Biologics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. It is developing Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are reprogrammed to pump out various cancer associated antigens together with a potent immune adjuvant. The company's products under development include HS-110 that is in Phase II clinical trials for the treatment of non-small cell lung cancer; HS-410 for the bladder cancer treatment; HS-310 to treat ovarian cancer; and HS-510 for treating triple negative breast cancer. Its products also comprise HS-HIV product candidate for the treatment and prevention of HIV. The company was founded in 2008 and is based in Chapel Hill, North Carolina.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Treatment Of Cancer Cancers Non Small Cell Lung Cancer Ovarian Cancer Vaccination Cancer Treatment HIV Platform Technology Vaccine Cancer Vaccine Treatment Of Non Small Cell Lung Cancer Biotechnology Companies Bladder Cancer Triple Negative Breast Cancer Chapel Hill Heat Biologics Neuvenge
Is HTBX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 18 Heat Biologics Announces Additional Top Line Phase 2 Data of HS-110 plus Nivolumab in Advanced NSCLC Patients at AACR Tumor Immunology and Immunotherapy Conference
Nov 15 Heat Biologics EPS misses by $0.05
Nov 15 Heat Biologics Reports Third Quarter 2019 Results and Provides Corporate Update
Nov 11 Heat Biologics Presents Additional Phase 2 Interim Data in Advanced NSCLC Patients at the SITC 34th Annual Meeting
Nov 8 Heat Biologics (HTBX) Investor Presentation - Slideshow
Nov 8 The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
Nov 7 We Think Heat Biologics (NASDAQ:HTBX) Needs To Drive Business Growth Carefully
Nov 5 Heat Biologics Reports Positive Phase 2 Interim Data in NSCLC Patients Who Previously Failed Checkpoint Inhibitor Treatment
Nov 2 Stocks To Watch: An Uber Exciting Week
Nov 1 Key events next week - healthcare
See more HTBX news...
Indicators
Indicator Value
52 Week High 2.1
52 Week Low 0.3616
Average Volume 260,013
200-Day Moving Average 0.8153
50-Day Moving Average 0.4812
20-Day Moving Average 0.4735
10-Day Moving Average 0.4602
Average True Range 0.0654
ADX 26.48
+DI 21.6446
-DI 16.4137
Chandelier Exit (Long, 3 ATRs ) 0.4526
Chandelier Exit (Short, 3 ATRs ) 0.5662
Upper Bollinger Band 0.5787
Lower Bollinger Band 0.3683
Percent B (%b) 0.29
BandWidth 44.435058
MACD Line -0.0081
MACD Signal Line -0.0013
MACD Histogram -0.0068
Fundamentals Value
Market Cap 15.39 Million
Num Shares 35.8 Million
EPS -0.43
Price-to-Earnings (P/E) Ratio -1.00
Price-to-Sales 26.16
Price-to-Book 2.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.49
Resistance 3 (R3) 0.49 0.47 0.48
Resistance 2 (R2) 0.47 0.45 0.47 0.48
Resistance 1 (R1) 0.45 0.45 0.44 0.45 0.47
Pivot Point 0.43 0.43 0.43 0.43 0.43
Support 1 (S1) 0.41 0.41 0.40 0.41 0.39
Support 2 (S2) 0.39 0.41 0.39 0.38
Support 3 (S3) 0.37 0.39 0.38
Support 4 (S4) 0.37